This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these messages)
|
| | |
| Formation | 2009 |
|---|---|
| Headquarters | 5636 Connecticut Avenue NW, PO Box 42735, Washington, D.C. 20015, U.S.A. |
| Location | |
Founder & President | Ramanan Laxminarayan |
| Website | onehealthtrust |
One Health Trust, formerly the Center for Disease Dynamics, Economics & Policy, is a public health research organization with offices in Washington, D.C., and Bangalore, India. [1]
Established in 2010, the organization announced its transition to becoming the One Health Trust in 2022 [2] to reflect an expanded research focus. This shift broadened the organization's scope of to include One Health topics, such as animal health, planetary health, and climate change. [3]
The One Health Trust has a multidisciplinary team comprising economists, epidemiologists, social scientists, microbiologists, veterinarians, medical doctors, and disease modelers. The One Health Trust research areas include antimicrobial resistance, zoonotic and vector borne diseases, environmental health, social determinants of health, vaccines and immunization, and other topics related to the One Health approach. [4]
The One Health Trust has been a World Health Organization Collaborating Center for antimicrobial resistance since 2020. The One Health Trust's researchers support the WHO in writing country-specific policy and information briefs reviewing progress in implementing national action plans on antimicrobial resistance as a World Health Organization Collaborating Center. [5] [6] [7]
As part of the Mapping Antimicrobial Resistance and Antimicrobial Use Partnership consortium, [8] One Health Trust conducted data surveillance and analysis in Africa to determine the extent of antimicrobial resistance in the continent. The consortium included the African Society for Laboratory Medicine, Africa Centers for Disease Control and Prevention, [9] [ circular reference ] West African Health Organization, East Central & Southern Africa Health Community, IQVIA,[ clarification needed ] and Innovative Support to Emergencies, Diseases and Disasters.
The project was funded by the Fleming Fund [10] and involved data collection on antimicrobial resistance from public and private laboratories and pharmacies throughout Africa. The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership consortium reviewed 819,584 antimicrobial resistance records from 2016-2019 from 205 laboratories across the 14 African Union Member States — Burkina Faso, Cameroon, Eswatini, Gabon, Ghana, Kenya, Malawi, Nigeria, Senegal, Sierra Leone, Tanzania, Uganda, Zambia, and Zimbabwe. [11]
The OxygenForIndia initiative was launched by One Health Trust and partnering institutions to address critical medical oxygen shortages in India. [12]
In April 2021, during a medical oxygen supply crisis, [13] [14] OxygenForIndia deployed 20,000 reusable oxygen cylinders and 3,000 oxygen concentrators in 57 urban and rural centers across India. Currently, OxygenForIndia is working to build a stable and reliable oxygen supply system [15] to avoid preventable deaths and improve pandemic preparedness. Researchers are evaluating fiscal initiatives and building India's health system capacities. [16]
With funding from the Gates Foundation, the One Health Trust is a technical partner in the Global Antibiotic Resistance Partnership, which was initiated in 2008 to help low- and middle-income countries develop country-led strategies and policies to address antimicrobial resistance. [17] [18] [19] [20]
One Health Trust was a member of the U.S. Centers for Disease Control and Prevention's MInD – Healthcare Network, which supported transmission modeling research to get insights on the drivers of healthcare-associated infections and antibiotic-resistant infections and estimate the benefits of preventive measures. [21]
The Affordable Medicines Facility — Malaria grew from a 2004 Institute of Medicines (IOM) report co-authored by the One Health Trust's president Dr. Ramanan Laxminarayan. [22] [ circular reference ] [23] The project addressed the issue of rising antimalarial drug resistance against the most commonly used malaria treatment at the time, chloroquine, by finding ways to get artemisinin-based combination therapies — the most effective malaria treatments known — into private pharmacies and village shops. [24] [25]
Through negotiating bulk orders and subsidies, the Affordable Medicines Facility - Malaria team worked to leverage existing private-sector infrastructure in Africa to get artemisinin-based combination therapies where there were none before, to lower prices of effective antimalarials in rural Africa. [26] [27]
The One Health Trust, in partnership with Birla Institute of Technology & Science (BITS) in Pilani, India, has a PhD program in Data Sciences for Global Health to provide training in global health issues and research methodology with fieldwork and data analysis. [28] This program is full-time. [29]
The One Health Trust's ResistanceMap is a collection of tools summarizing national and subnational data on antimicrobial use and resistance globally. [30] Since its launch in 2010, ResistanceMap has been used to provide information on trends in drug resistance and antibiotic use. [31] [32]
In 2015, ResistanceMap was updated with a new design interface, expanded tools, and the addition of antibiotic use and resistance data from several low- and middle-income countries in Africa, Asia and South America. [33]
The One World, One Health podcast [34] by the One Health Trust was launched in 2022. The podcast is interview-style and the host, Maggie Fox, talks to scientific researchers about topics including pandemics, antimicrobial resistance, the impact of deforestation on human health, among other related issues.